trending Market Intelligence /marketintelligence/en/news-insights/trending/ZUbTk48nhW1xerSms_yBtg2 content esgSubNav
In This List

Kite Pharma CEO steps down from Teva board

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Kite Pharma CEO steps down from Teva board

Arie Belldegrun resigned from the Teva Pharmaceutical Industries Ltd. board to focus on his responsibilities at Kite Pharma Inc.

Belldegrun is the chairman, president, CEO and founder of Kite Pharma. He joined the Teva board in 2013.